Research Article
Gypenoside-Induced Apoptosis via the PI3K/AKT/mTOR Signaling Pathway in Bladder Cancer
Table 1
Bioactive compounds of gypenosides.
| Mol ID | Molecule Name | OB (%) | DL |
| MOL009888 | Gypenoside XXXVI_qt | 37.85 | 0.78 | MOL009928 | Gypenoside LXXIV | 34.21 | 0.24 | MOL009929 | Gypenoside LXXIX | 37.75 | 0.25 | MOL009938 | Gypenoside XII | 36.43 | 0.25 | MOL009943 | Gypenoside XL | 30.89 | 0.21 | MOL009969 | Gypenoside XXXV_qt | 37.73 | 0.78 | MOL009971 | Gypenoside XXVII_qt | 30.21 | 0.74 | MOL009973 | Gypenoside XXVIII_qt | 32.08 | 0.74 | MOL009976 | Gypenoside XXXII | 34.24 | 0.25 | MOL009986 | Gypentonoside A_qt | 36.13 | 0.8 |
|
|
Abbreviations: OB, oral bioavailability; DL, drug-likeness.
|